Epstein-Barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene

Journal of Medical Virology

Volumn 73, Issue 4, 2004, Pages 583-588

  Correa, Rita Mariel ^a,b   Fellner, María Dolores ^a   Alonio, Lidia Virginia ^a   Durand, Karina ^a   Teyssié, Angélica R ^a   Picconi, María Alejandra ^a  

^a Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^b NONE   (Argentina)

Author keywords

Blood donors; Del LMP 1; EBV; LMP 1; PCR; Type

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 2; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 3A; ESPTEIN BARR VIRUS NUCLEAR ANTIGEN 3C; LATENT MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; AGED; ARGENTINA; ARTICLE; BASE PAIRING; BLOOD BANK; EPSTEIN BARR VIRUS; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; LATENT MEMBRANE PROTEIN 1 ONCOGENE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SUPERINFECTION; VIRUS CARRIER; VIRUS GENOME; VIRUS INFECTION; VIRUS ONCOGENE;

ADOLESCENT; ADULT; AGED; ARGENTINA; BLOOD DONORS; CARRIER STATE; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENOTYPE; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE DELETION; VARIATION (GENETICS); VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4; STAPHYLOCOCCUS PHAGE 3A;

EID: 3042782463     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20129     Document Type: Article

References (36)

1. Apolloni A, Sculley TB. 1994. Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology 202:978-981.
2. Arrand JR, Young LS, Tugwood JD. 1989. Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. J Virol 63:983-986.
3. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
4. Berger C, McQuain C, Sullivan JL, Nadal D, Quesenberry PJ, Knecht H. 1997. The 30-bp deletion variant of Epstein-Barr virus-encoded latent membrane protein-1 prevails in acute infectious mononucleosis. J Infect Dis 176:1370-1373.
5. Buck M, Cross S, Krauer K, Kienzle N, Sculley TB. 1999. A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle. J Gen Virol 80:441-445.
6. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS. 1992. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131-2140.
7. Chen W-G, Chen Y-Y, Bachi MM, Bachi CE, Alvarenga M, Weiss LM. 1996. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Am J Pathol 148:17-23.
8. Dirnhofer S, Angeles-Angeles A, Ortiz-Hidaldo C, Reyes E, Gredler E, Krugmann J, Fend F, Quintanilla-Martinez L. 1999. High prevalence of a 30-Base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican Classical Hodgkin's disease and reactive lymphoid tissue. Hum Pathol 30:781-787.
9. Dolcetti R, Zancai P, De Re V, Gloghini A, Bigoni B, Pivetta B, De Vita S, Carbone A, Boiocchi M. 1997. Epstein-Barr virus strains with latent membrane protein-1 deletions: Prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. Blood 89:1723-1731.
10. Falk KI, Zou J, Lucht E, Linde A, Ernberg I. 1997. Direct identification by PCR of EBV types and variants in clinical samples. J Med Virol 51:355-363.
11. Gratama JW, Ernberg I. 1995. Molecular epidemiology of Epstein Barr virus infection. Adv Cancer Res 67:197-255.
12. Khanim F, Yao QY, Niedobitek G, Sihota S, Rickinson AB, Young LS. 1996. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 88:3491-3501.
13. Kieff E. 1996. Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM, editors. Virology, Vol 2, 3th edition. Philadelphia: Lippincott-Raven. pp 2343-2396.
14. Knecht H, Bachmann E, Bruosset P, Sandvej K, Nadadl D, Bachmann F, Odermatt B, Delsol G, Pallesen G. 1993. Deletions within the LMP-1 oncogene of Epstein barr virus are clustered in Hodgkin's disease and identical to those observed in Nasopharyngeal Carcinoma. Blood 82:2937-2942.
15. Maniatis T, Fritsch E, Sambrook J. 1989. Molecular cloning: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
16. Miller G, Lipman M. 1973. Release of infectious Epstein Barr virus by transformed marmoset leucocytes. Proc Natl Acad Sci USA 70:190-194.
17. Miller G, Robinson L, Heston L, Lipman M. 1974. Differences between laboratory strain of Epstein Barr virus based on inmortalization, abortive infection and interference. Proc Natl Acad Sci USA 71:4006-4010.
18. Rickinson AB, Kieff E. 1996. Epstein Barr virus. In: Fields BN, Knipe DM, Howley PM, editors. Virology, Vol 2, 3th edition. Philadelphia: Lippincott-Raven. pp 2397-2446.
19. Saiki RK, Gelfand DH, Stoffel S, Higuchi H, Horn GT, Mullis KB, Erlich HA. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
20. Sample J, Hummel M, Braun D, Birkenbach M, Kieff E. 1986. Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: A probable transcriptional initiation site. Proc Natl Acad Sci USA 83:5096-5100.
21. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E. 1990. Epstein-Barr Types 1 and 2 differ in their EBNA-3A, EBNA-3B and EBNA-3C genes. J Virol 64:4084-4092.
22. Sandvej K, Peh S-C, Storstein Andersen B, Pallesen G. 1994. Identification of potential hotspots in the carboxy-terminal part of the Epstein-Barr (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: High frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 84:4053-4060.
23. Santón A, Martín C, Manzanal AI, Preciado MV, Bellas C. 1998. Paediatric Hodgkin's disease in Spain: Association with Epstein-Barr virus strains carrying latent membrane protein-1 oncogene deletions and high frequency of dual infections. Br J Hematol 103:129-136.
24. Sculley T, Krauer K, Kienzle N. 1999. Comparison of A-type and B-type Epstein-Barr virus. Epstein-Barr Virus Report 6:1-6.
25. Sigadis J, Ueno K, Tokunaga M, Ohyama M, Eizuru Y. 1997. Molecular epidemiology of Epstein-Barr virus (EBV) in EBV-related malignancies. Int J Cancer 72:72-76.
26. Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L. 1989. Detection of a second widespread strain of Epstein-Barr virus. Lancet 2:761-765.
27. Smir B, Hauke R, Bierman P, Gross T, d'Amore F, Anderson J, Greiner T. 1996. Molecular epidemiology of deletion and mutation of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphofroliferative disorders. Lab Invest 75:575-588.
28. Srivastava G, Wong KY, Chiang AK, Lam KY, Tao Q. 2000. Coinfection of multiple strain of Epstein-Barr virus in immunocompetent normal individuals: Reassessment of the viral carrier state. Blood 95:2443-2445.
29. van Baarle D, Hovenkamp E, Kersten MJ, Klein M, Miederna F, van Oers MH. 1999. Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: No association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 11:3949-3955.
30. Vasef M, Kamel O, Chen Y-Y, Medeiros LJ, Weiss L. 1995. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am J Pathol 147:1405-1415.
31. Wagner HJ, Bein G, Bitsch A, Kirchner HJ. 1992. Detection and quantitation of latently infected B-lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J Clin Microbiol 30:2826-2829.
32. Walling D, Brown A, Etienne W, Kietel E, Ling P. 2003. Multiple Epstein Barr virus infection in healthy individuals. J Virol 77:6546-6550.
33. Yao QY, Rowe M, Martin B, Young LS, Rickinson AB. 1991. The Epstein-Barr virus carrier state: Dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J Gen Virol 72:1579-1590.
34. Yao QY, Tierney RJ, Croom-Carter D, Cooper GM, Ellis CJ, Rowe M, Rickinson AB. 1996. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell immunocompromised individuals. J Virol 70:4895-4903.
35. Yao QY, Croom-Carter DS, Tierney RJ, Habeshaw G, Wilde JT, Hill FG, Conlon C, Rickinson AB. 1998. Epidemiology of infection with Epstein-Barr virus type 1 and 2: Lesson from the study of a T-cell immunocompromised hemophilic cohort. J Virol 72:4352-4363.
36. Zimber U, Adldinger HK, Lenoir GM, Vuillaume M, Knebel-Doeberitz MV, Laux G, Desgranges C, Wittmann P, Freese UK, Schneider U, Bornkamm G. 1986. Geographical prevalence of two types of Epstein-Barr virus. Virology 154:56-66.